Opinion

Video

Emerging Therapies for Dry Eye Disease

Author(s):

William B. Trattler, MD,Crystal Brimer, OD, FAAO

Crystal Brimer, OD, and Kelly K. Nichols, OD, MPH, PhD, discuss two treatments, AZR-MD-001 and Reproxalap, that are in the pipeline to treat patients with dry eye disease (DED).

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Cochair Kelly K. Nichols, OD, PhD, MPH, FAAO, highlights her passion for dry eye research and the vital collaboration between ophthalmology and optometry
Alice Epitropoulos, MD, and Laura M. Periman, MD
Alice Epitropoulos, MD, and Laura M. Periman, MD
Alice Epitropoulos, MD, and Laura M. Periman, MD
Alice Epitropoulos, MD, and Laura M. Periman, MD
Alice Epitropoulos, MD, and Laura M. Periman, MD
Alice Epitropoulos, MD, and Laura M. Periman, MD
Alice Epitropoulos, MD, and Laura M. Periman, MD
Related Content
Harrow expands VEVYE Access for All program to Klarity-C patients
April 11th 2025

Harrow expands VEVYE Access for All program to Klarity-C patients

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 4)
September 13th 2023

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 4)

Doctors warn TikTok & Instagram reels may be damaging eyes long-term
April 4th 2025

Doctors warn TikTok & Instagram reels may be damaging eyes long-term

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 3)
September 13th 2023

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 3)

Labtician Ophthalmics announces commercial launch of Lab TRIACTIV
March 29th 2025

Labtician Ophthalmics announces commercial launch of Lab TRIACTIV

Bausch + Lomb publishes results from phase 4 study evaluating patient-reported outcomes with Miebo in dry eye disease
March 24th 2025

Bausch + Lomb publishes results from phase 4 study evaluating patient-reported outcomes with Miebo in dry eye disease

© 2025 MJH Life Sciences

All rights reserved.